Michaela Winkelmann

Articles translated into German by Michaela Winkelmann

• 2024 HDBuzz Prize: Thinking beyond therapies - it’s time to consider racial disparity in HD care and research
• HDBuzz needs your help
• Hats off to brain donors on Brain Donation Awareness Day
• 14 changes for a healthier brain
• Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial
• Two birds, one stone: HTT-lowering drugs also target CAG expansions
• Cry your eyes out: detecting huntingtin in tears
• The director’s cut: how CAG repeats change the editing of genetic messages
• Oz Buzz Video: Day 1
• Tipping the balance; new insights into HD genetic modifiers
• Huntington’s disease therapeutics conference 2023 - Day 3
• Huntington’s disease therapeutics conference 2023 - Day 2
• Huntington’s disease therapeutics conference 2023 - Day 1
• PROOF-HD study of pridopidine ends with negative result
• Astrocytes: The new star in HD research?
• Hunting for balance: how the huntingtin protein compensates in HD
• Sad news from Novartis: dosing suspended in VIBRANT-HD trial of branaplam
• Updates from uniQure about their gene therapy for Huntington's disease
• Vaccines and HD
• A faulty filter? Blood vessel changes in Huntington's disease
• EuroBuzz 2014 Video, day one
• Artificial intelligence to save the day? How clever computers are helping us understand Huntington’s disease.
• A new roadmap to track Huntington’s disease progression
• Shining a spotlight on huntingtin: a tool to measure huntingtin-lowering in real time
• BAC to basics: a more accurate mouse model for Huntington's disease
• What does COVID-19 mean for Huntington’s disease families and HD research?
• Huntington’s disease therapeutics conference 2022 - Day 2
• Huntington’s disease therapeutics conference 2022 - Day 3
• Important drug targets yielded by new genetic study of HD
• Through a Broader Lens: Looking at Non-Motor Symptoms in HD
• Treasure your exceptions - using outliers to understand Huntington's disease onset and progression
• Ultra-rare mutations highlight the importance of the HD gene in brain development
• Huntington's Disease Therapeutics Conference 2016 - day 3
• Huntington's Disease Therapeutics Conference 2016 - day 2
• Early exposure to the HD protein may cause life-long symptoms
• A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
• Electron beam snaps best images yet of Huntington's disease protein
• Looking Past the Spin: Results from a Clinical Trial of Cysteamine
• Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
• Taking new targets to the bank: the DNA repair protein ‘ATM’ is overactive in Huntington's disease
• Measuring harmful huntingtin protein in the brain’s bath water
• 2015 Huntington's Disease Therapeutics Conference: Day 3
• Buzzilia Video: Day 2
• 2015 Huntington's Disease Therapeutics Conference: Day 2
• 2015 Huntington's Disease Therapeutics Conference: Day 1
• Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease
• Drug Improves Huntington’s Symptoms in Mice – and Their Offspring
• mTORC1 tips the scales in Huntington’s disease mice
• Can this synthetic oil help feed the brain in Huntington's disease?
• Positive results announced for re-worked tetrabenazine drug in Huntington's disease
• EuroBuzz 2014: day one
• Turning skin cells into brain cells: a Huntington's disease research breakthrough?
• Melatonin alterations in Huntington's disease help explain trouble with sleep
• Should we worry about a huntingtin invasion?
• Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
• Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
• EuroBuzz 2014: day two
• EuroBuzz 2014: day three
• A starring role for astrocytes in Huntington's disease?
• The brain in Huntington's disease: greater than the sum of its parts?
• Raptor announces results of cysteamine trial for Huntington's disease
• NUB1: enhancing clearance to decrease mutant huntingtin
• 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
• HD mice provide a useful failure
• Buzzilia Video: Day 1
• Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
• Sleep, cilia and HD
• Huntington's Disease Therapeutics Conference 2014: day 2
• Huntington's Disease Therapeutics Conference 2014: day 3
• Huntington's Disease Therapeutics Conference 2014: day 1
• 2012 Therapeutics Conference: a retrospective
• Video feature: Huntington's disease research... in space!
• Does high-dose creatine "slow the onset" of Huntington's Disease?
• Joint HDBuzz Prizewinner: Yeast studies suggest a new way to protect cells from 'oxidative damage'
• Interview: Alice and Nancy Wexler
• Is a new technique set to revolutionize Huntington's disease genetic testing?
• Can sad mice help treat Huntington's disease?
• Simple rules for a good night's sleep in Huntington's disease
• Joint HDBuzz Prizewinner: Pennies for your neurons — copper’s bad influence on Huntington’s disease
• Could a 'brain shuttle' get Huntington's disease drugs to where they're needed?
• HD Therapeutics Conference 2013 Updates: Day 3
• Coming soon from the 2013 Huntington's Disease World Congress: Buzzilia!
• 'Buzzilia' from the Huntington's Disease World Congress: day 2
• Is a new Huntington’s Disease drug study on the right Trk?
• DNA shutdown proteins in Huntington's disease: More than meets the eye
• Do dairy foods accelerate Huntington's disease?
• More evidence points to Huntington's disease exercise benefit
• New study sheds light on regional degeneration in HD
• Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
• Does a 'rusty hinge' cause Huntington's disease?
• What the 'big neurodegeneration breakthrough' means for Huntington's disease
• Could muscle problems help explain movements in Huntington’s Disease patients?
• 'Buzzilia' from the Huntington's Disease World Congress: day 1
• How long is too long? Rethinking the Huntington’s disease ‘gray area’
• 'Buzzilia' from the Huntington's Disease World Congress: day 3
• The sweet lowdown: Huntington's disease brains use sugar differently
• The 2013 HDBuzz Prize for Young Science Writers
• 'Buzzilia' from the Huntington's Disease World Congress: day 4
• The 'N17' region of huntingtin protein: an address label in Huntington's disease?
• Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
• Proposed Huntington's disease 'biomarker' is not useful, new study suggests
• No surprises in published results from HART study of Huntexil for Huntington's disease
• Lost in translation? New insights into the making of the Huntington's disease protein
• A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
• Gene silencing drug safe in ALS patients... bring on Huntington's disease trials
• Start here!
• Major Roche-Isis deal boosts Huntington's disease gene silencing
• Landmark study puts Huntington's disease trials on TRACK
• Prana Biotech publishes Huntington's disease animal model data for PBT2
• The University of New Orleans has NOT discovered a cure for Huntington's disease
• Prominent Huntington's disease researcher "fabricated data" in grant applications
• Of mice and men: using animal models to study Huntington's disease
• Illuminating findings in blood cells from Huntington's disease patients
• HDBuzz Prize winner 2012: Deep brain stimulation for HD
• HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
• Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
• EuroBuzz News: Day 2
• EuroBuzz News: Day 3
• Does the HD mutation affect children's growth?
• ASO gene silencing reaches further, lasts longer
• The HDBuzz Prize for young science writers
• Exercise increases cellular recycling
• Making babies: having a family, the HD way
• Double success for huntingtin RNAi gene silencing
• New analysis suggests 'small' CAG length doesn't matter after all
• Special 'brain fat' injection helps HD mice
• HDYO! Huntington's Disease Youth Organization goes live
• CHDI Report: Day 1
• CHDI Report: Day 2
• Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
• Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
• Could mesenchymal stem cells deliver gene silencing drugs?
• Therapeutics conference videos now online
• Coming soon from the HD World Congress: Oz Buzz!
• Dimebon fails in late-stage human HD clinical trial
• Huntexil hits the headlines again
• Chinese Huntington’s Disease Network launched
• Bone marrow transplantation in Huntington's Disease
• New experiments clarify the role of SIRT1 in HD - or do they?